Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
Department of Laboratory Medicine, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul, Republic of Korea.
J Hosp Infect. 2019 Dec;103(4):420-427. doi: 10.1016/j.jhin.2019.08.018. Epub 2019 Sep 4.
The effects of early central venous catheter (CVC) removal on the clinical outcomes of patients with candidaemia remain controversial. This study evaluated the impact of delayed CVC removal on mortality according to the severity of comorbidities in patients with candidaemia.
Patients with candidaemia in a tertiary care hospital between January 2010 and December 2017 were included retrospectively. The severity of comorbidities was classified as low [Charlson Comorbidity Index (CCI) score ≤3] or high (CCI score ≥4). Cases with removal of CVC >2 days after the onset of candidaemia or without CVC removal were classified as having delayed CVC removal.
In total, 239 patients with candidaemia were included, excluding 18 who died within 2 days of onset of candidaemia. Of these, 149 had low CCI scores and 90 had high CCI scores. Septic shock [adjusted odds ratio (aOR)=9.5] and delayed CVC removal (aOR=4.7) were significantly associated with increased 30-day mortality, whereas Candida parapsilosis infection (aOR=0.2) and cerebrovascular disease (aOR=0.3) were associated with decreased 30-day mortality, in patients with low CCI scores. Septic shock (aOR=13.0) was the only risk factor for 30-day mortality in those with high CCI scores. Delayed CVC removal was associated with increased 30-day mortality in patients with low CCI scores (50.0% vs 20.3%; P=0.001), but not in those with high CCI scores (50.0% vs 47.9%; P=0.87).
Early CVC removal may improve the survival of patients with candidaemia and low CCI scores, but no such protective effect was evident in those with high CCI scores.
早期中心静脉导管(CVC)拔除对念珠菌血症患者临床结局的影响仍存在争议。本研究评估了念珠菌血症患者合并症严重程度对 CVC 延迟拔除与死亡率的影响。
回顾性纳入 2010 年 1 月至 2017 年 12 月期间一家三级医院的念珠菌血症患者。合并症严重程度分类为低危(Charlson 合并症指数[CCI]评分≤3)或高危(CCI 评分≥4)。CVC 拔除时间延迟(念珠菌血症发病后>2 天拔除 CVC 或未拔除 CVC)的病例被分类为 CVC 延迟拔除。
共纳入 239 例念珠菌血症患者,排除了 18 例发病后 2 天内死亡的患者。其中 149 例 CCI 评分低,90 例 CCI 评分高。脓毒症性休克(调整后的优势比[aOR]=9.5)和 CVC 延迟拔除(aOR=4.7)与 30 天死亡率增加显著相关,而近平滑念珠菌感染(aOR=0.2)和脑血管病(aOR=0.3)与 CCI 评分低的患者 30 天死亡率降低相关。脓毒症性休克(aOR=13.0)是 CCI 评分高的患者 30 天死亡率的唯一危险因素。CVC 延迟拔除与 CCI 评分低的患者 30 天死亡率增加相关(50.0% vs. 20.3%;P=0.001),但与 CCI 评分高的患者无关(50.0% vs. 47.9%;P=0.87)。
早期 CVC 拔除可能改善 CCI 评分低的念珠菌血症患者的生存率,但在 CCI 评分高的患者中未观察到这种保护作用。